Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for the PATHWAY ...

Should I get breast implants? Should they be saline or silicone? Which style? How much monitoring is needed after surgery?

Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

Author, speaker and health content creator Dr Liz O’Riordan shares her journey from consultant breast surgeon to cancer ...

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved, the ...

The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...

As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast ...

Time is important with a cancer diagnosis so that treatment can be started early before cancer spreads.” - Dr. Hazem Abdel Samie, Managing Director of MSD Egypt ClusterCAIRO, EGYPT, January 31, 2025 ...

A recent study published in JAMA explored whether getting telehealth visits, rather than in-person visits, affects the ...

D tumoroid models transform cancer research, accurately reflecting tumor biology and enabling effective drug testing and ...

A breast cancer diagnosis often arrives as a profound turning point, bringing uncertainty and complex emotions. While the ...

Cancers, especially breast cancer, could kill 5.5 million women in 2030 compared to 3.5 million in 2012. A tragic scenario ...